Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gynecologic 1Classical hematology 1

Conditions

Lung Neoplasms 5Small Cell Lung Carcinoma 4Mesothelioma 3Neoplasms 2Neoplasm Metastasis 2Mesothelioma, Malignant 2Carcinoma, Non-Small-Cell Lung 2Uveal Melanoma 1Urologic Neoplasms 1Stomach Neoplasms 1SCLC,Extensive Stage 1Recurrence 1Pancreatic Neoplasms 1Melanoma 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Carcinoma, Neuroendocrine 1Carcinoma 1Breast Neoplasms 1Anus Neoplasms 1

Interventions

Docetaxel 8pembrolizumab 7Pemetrexed 5Carboplatin 5Erlotinib Hydrochloride 4toripalimab 3rociletinib 3fludarabine 3Radiosurgery 3Paclitaxel 3Oxaliplatin 3Nivolumab 3Gemcitabine 3Etoposide 3Cyclophosphamide 3Cisplatin 3Bevacizumab 3lorlatinib 2atezolizumab 2Vinorelbine 2Topotecan 2Radiotherapy 2Platinum 2Itraconazole 2Irinotecan 2Interleukin-2 2Cetuximab 2Albumin-Bound Paclitaxel 2vinflunine 1vandetanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × niraparib × Thoracic × Clear all
NCT05455424 2025-05-15

NERO

University Hospital Southampton NHS Foundation Trust

Phase 2 Completed
88 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡